Compare Quest Diagnostics Inc (DGX) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Nuwellis Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Quest Diagnostics Inc is far larger — about 48286.7× Nuwellis Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| DGX | NUWE | |
|---|---|---|
Market Cap | $26.21B | $542.80K |
Sector | Health | Technology |
52-Week High | $238.50 | $220.50 |
52-Week Low | $173.49 | $1.42 |
Enterprise Value | $31.97B | -$1.27M |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
